206 related articles for article (PubMed ID: 25422169)
1. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
Brooks AM; Oram R; Home P; Steen N; Shaw JA
Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
[TBL] [Abstract][Full Text] [Related]
2. Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).
Vantyghem MC; Raverdy V; Balavoine AS; Defrance F; Caiazzo R; Arnalsteen L; Gmyr V; Hazzan M; Noël C; Kerr-Conte J; Pattou F
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2078-83. PubMed ID: 22996144
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).
Baidal DA; Ballou CM; Rickels MR; Berney T; Pattou F; Payne EH; Barton FB; Alejandro R;
Diabetes Care; 2023 Apr; 46(4):697-703. PubMed ID: 36657975
[TBL] [Abstract][Full Text] [Related]
4. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
[TBL] [Abstract][Full Text] [Related]
5. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
6. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
[TBL] [Abstract][Full Text] [Related]
8. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
[TBL] [Abstract][Full Text] [Related]
9. Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.
Forbes S; Oram RA; Smith A; Lam A; Olateju T; Imes S; Malcolm AJ; Shapiro AM; Senior PA
Am J Transplant; 2016 Sep; 16(9):2704-13. PubMed ID: 27017888
[TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up after clinical islet transplantation.
Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
[TBL] [Abstract][Full Text] [Related]
11. Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.
Hope SV; Knight BA; Shields BM; Hill AV; Choudhary P; Strain WD; McDonald TJ; Jones AG
Diabetologia; 2018 Jan; 61(1):66-74. PubMed ID: 28983693
[TBL] [Abstract][Full Text] [Related]
12. Beta-score: an assessment of beta-cell function after islet transplantation.
Ryan EA; Paty BW; Senior PA; Lakey JR; Bigam D; Shapiro AM
Diabetes Care; 2005 Feb; 28(2):343-7. PubMed ID: 15677790
[TBL] [Abstract][Full Text] [Related]
13. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation.
Graham ML; Bellin MD; Papas KK; Hering BJ; Schuurman HJ
Xenotransplantation; 2011; 18(6):328-42. PubMed ID: 22168140
[TBL] [Abstract][Full Text] [Related]
14. Long-term function (6 years) of islet allografts in type 1 diabetes.
Alejandro R; Lehmann R; Ricordi C; Kenyon NS; Angelico MC; Burke G; Esquenazi V; Nery J; Betancourt AE; Kong SS; Miller J; Mintz DH
Diabetes; 1997 Dec; 46(12):1983-9. PubMed ID: 9392484
[TBL] [Abstract][Full Text] [Related]
15. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
[TBL] [Abstract][Full Text] [Related]
16. Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations.
Brooks AM; Walker N; Aldibbiat A; Hughes S; Jones G; de Havilland J; Choudhary P; Huang GC; Parrott N; McGowan NW; Casey J; Mumford L; Barker P; Burling K; Hovorka R; Walker M; Smith RM; Forbes S; Rutter MK; Amiel S; Rosenthal MJ; Johnson P; Shaw JA
Am J Transplant; 2013 Dec; 13(12):3236-43. PubMed ID: 24119216
[TBL] [Abstract][Full Text] [Related]
17. Islet autotransplantation to preserve beta cell mass in selected patients with chronic pancreatitis and diabetes mellitus undergoing total pancreatectomy.
Bellin MD; Beilman GJ; Dunn TB; Pruett TL; Chinnakotla S; Wilhelm JJ; Ngo A; Radosevich DM; Freeman ML; Schwarzenberg SJ; Balamurugan AN; Hering BJ; Sutherland DE
Pancreas; 2013 Mar; 42(2):317-21. PubMed ID: 23146918
[TBL] [Abstract][Full Text] [Related]
18. Early metabolic markers of islet allograft dysfunction.
Baidal DA; Faradji RN; Messinger S; Froud T; Monroy K; Ricordi C; Alejandro R
Transplantation; 2009 Mar; 87(5):689-97. PubMed ID: 19295313
[TBL] [Abstract][Full Text] [Related]
19. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
[TBL] [Abstract][Full Text] [Related]
20. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
